Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Brain Research

• Publication date

  1994-12-19

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-8993(94)91709-4PMID 7895080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change

  2004cited by this paper
• Diffuse Lewy body disease

  2004cited by this paper
• Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques

  2004cited by this paper
• Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus

  2004cited by this paper
• Neuronal inputs to hippocampal formation in Alzheimer's disease and in parkinsonism-dementia complex on Guam

  2004cited by this paper
• Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains.

  1994cited by this paper
• Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa

  1993cited by this paper
• Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists.

  1993cited by this paper
• Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia.

  1993cited by this paper
• Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies.

  1993cited by this paper
• Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex.

  1993cited by this paper
• Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions.

  1992cited by this paper
• Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles.

  1992cited by this paper
• Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson's disease.

  1992cited by this paper
• Three-Dimensional Analysis of the Relationship Between Synaptic Pathology and Neuropil Threads in Alzheimer Disease

  1992cited by this paper
• Characterization of a synaptic antigen of interest in neuropsychiatric illness.

  1992cited by this paper
• Regional synaptic pathology in Alzheimer's disease.

  1992cited by this paper
• Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.

  1991cited by this paper
• Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease.

  1991cited by this paper
• Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

  1990cited by this paper
• Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections.

  1990cited by this paper
• The Lewy body variant of Alzheimer's disease

  1990cited by this paper
• Diffuse lewy body disease in Japan

  1990cited by this paper
• Diffuse plaques do not accentuate synapse loss in Alzheimer's disease.

  1990cited by this paper
• Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease

  1989cited by this paper
• Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.

  1989cited by this paper
• Synaptic loss in Alzheimer's disease and other dementias

  1989cited by this paper
• Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.

  1989cited by this paper
• Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease

  1988cited by this paper
• Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone

  1987cited by this paper
• Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients

  1987cited by this paper
• Perforant pathway changes and the memory impairment of Alzheimer's disease

  1986cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles.

  1985cited by this paper
• Cell biology of synaptic plasticity.

  1984cited by this paper
• Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

  1984cited by this paper
• Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections

  1983cited by this paper
• Some morphometric aspects of the brain in senile dementia of the alzheimer type

  1981cited by this paper
• Subcortical afferents to the hippocampal formation in the monkey

  1980cited by this paper
• Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system

  1976cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• The synaptic organization of the brain: An introduction

  1974cited by this paper
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

  1968cited by this paper

• Distinct regional patterns of synaptic vulnerability across hippocampal and parahippocampal subregions in Alzheimer's disease.

  2026cites this paper
• Primary age-related tauopathy

  2025cites this paper
• Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer’s disease

  2025cites this paper
• Transcriptional Signatures of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer’s Disease

  2023cites this paper
• Spatial proteomics of hippocampal subfield‐specific pathology in Alzheimer's disease and primary age‐related tauopathy

  2023cites this paper
• Hippocampal Synaptic Alterations Associated with Tau Pathology in Primary Age-Related Tauopathy

  2023cites this paper
• Synapses, Microglia, and Lipids in Alzheimer’s Disease

  2022cites this paper
• N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases

  2022cites this paper
• A comparative study of pre‐alpha islands in the entorhinal cortex from selected primates and in lissencephaly

  2021cites this paper
• What causes neurodegenerative disease?

  2020cites this paper
• Potential therapeutic role of carnitine and acetylcarnitine in neurological disorders.

  2020cites this paper
• Blood extracellular vesicles (EVs) of central nervous system origin: a window into the brain

  2019cites this paper
• SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s Disease

  2019cites this paper
• The synaptic pathology of cognitive life


  2019cites this paper
• Synaptic Elimination in Neurological Disorders

  2019cites this paper
• Culling Less Fit Neurons Protects against Amyloid-β-Induced Brain Damage and Cognitive and Motor Decline

  2018cites this paper
• Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer’s disease

  2017cites this paper
• Synaptic phosphorylated &agr;-synuclein in dementia with Lewy bodies

  2017cites this paper
• N-Acetylcysteine: A Natural Antidote for Alzheimer's Disease

  2016cites this paper
• Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease.

  2016cites this paper
• Meta‐analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability

  2016cites this paper
• Truncated tau deregulates synaptic markers in rat model for human tauopathy

  2015influential citation
• Tau-mediated synaptic damage in Alzheimer’s disease

  2015cites this paper
• Overexpression of Heme Oxygenase 1 Impairs Cognitive Ability and Changes the Plasticity of the Synapse

  2015cites this paper
• DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice

  2015cites this paper
• The Neural and Behavioral Profile of Older Adults at Risk for Developing Mild Cognitive Impairment

  2015cites this paper
• Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons

  2014cites this paper
• Pathophysiology of Parkinson's disease behavior--a view from the network.

  2014cites this paper
• Is synaptic loss a unique hallmark of Alzheimer's disease?

  2014cites this paper
• Role of ionotropic glutamate receptors in neurodegenerative and other disorders

  2014cites this paper
• Molecular changes during the development of Alzheimer's disease

  2013cites this paper
• Studying synapses in human brain with array tomography and electron microscopy

  2013cites this paper
• The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease

  2013cites this paper
• Molecular changes during the development of Alzheimer's disease General introduction Early molecular changes in Alzheimer Disease - can we catch the disease in its presymptomatic phase? 1 that

  2013cites this paper
• Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?

  2013cites this paper
• Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies

  2013cites this paper
• What causes alzheimer's disease?

  2013cites this paper
• Synaptic Mitochondrial Pathology in Alzheimer's Disease

  2012cites this paper
• Reducing perceptual interference improves visual discrimination in mild cognitive impairment: Implications for a model of perirhinal cortex function

  2012cites this paper
• Efectos del envejecimiento y la neurodegeneración sobre la plasticidad neuronal en el hipocampo

  2011cites this paper
• Neuropathology of Dementia in Parkinson's Disease

  2011cites this paper
• Reversing EphB2 depletion rescues cognitive functions in Alzheimer model

  2011cites this paper
• Parkinson's Disease Dementia and Potential Therapeutic Strategies

  2011cites this paper
• Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.

  2011influential citation
• The morbid anatomy of dementia in Parkinson’s disease

  2009cites this paper
• Synaptic degeneration in Alzheimer’s disease

  2009influential citation
• Lewy Body Variant of Alzheimer's Disease: Selective Neocortical Loss of t-SNARE Proteins and Loss of MAP2 and α-Synuclein in Medial Temporal Lobe

  2009cites this paper
• VAMP2 is expressed in muscle satellite cells and up-regulated during muscle regeneration

  2007cites this paper
• Loss of synaptophysin and synaptosomal‐associated protein 25‐kDa (SNAP‐25) in elderly Down syndrome individuals

  2007cites this paper
• Glutamate-glutamine cycling in Alzheimer's disease.

  2007cites this paper
• Short Communication Abnormal Accumulation of NACPIa--Synuclein in Neurodegenerative Disorders

  2007cites this paper
• Lewy Body Disorders

  2007cites this paper
• Pathophysiology of synuclein aggregation in Lewy body disease.

  2006cites this paper
• Synaptic remodeling during aging and in Alzheimer's disease

  2006cites this paper
• Alzheimer's disease-related alterations in synaptic density: Neocortex and hippocampus

  2006cites this paper
• Synaptic Pathology in Dementia

  2006cites this paper
• Relevance of Presynaptic Proteins to Neuropsychiatric Disorders

  2006cites this paper
• Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease.

  2005cites this paper
• Pathology of dementia with Lewy bodies

  2005cites this paper
• Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease

  2005cites this paper
• Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.

  2005cites this paper
• Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease

  2004cites this paper
• Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies.

  2003cites this paper
• Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity.

  2003cites this paper
• Cycles of Aberrant Synaptic Sprouting and Neurodegeneration in Alzheimer's and Dementia with Lewy Bodies

  2003cites this paper
• Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals.

  2003cites this paper
• Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.

  2002cites this paper
• Neuroimaging in Dementia with Lewy Bodies: Metabolism, Neurochemistry, and Morphology

  2002cites this paper
• Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness.

  2002cites this paper
• Reversal of amyloid β toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid β antibody

  2002cites this paper
• Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration?

  2002cites this paper
• Acetyl-l-carnitine as a possible therapy for Alzheimer’s disease

  2002cites this paper
• Chronic elevation of amyloid precursor protein in the neocortex or hippocampus of marmosets with selective cholinergic lesions

  2001cites this paper
• Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization.

  2001cites this paper
• Synaptic Pathology in Prefrontal Cortex is Present Only with Severe Dementia in Alzheimer Disease

  2001cites this paper
• Cortical Synapse Loss in Progressive Supranuclear Palsy

  2001cites this paper
• Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression

  2000cites this paper
• Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.

  2000cites this paper
• Cortical Neuropathology in Aging and Dementing Disorders

  1999cites this paper
• The occurrence of depressive symptoms in the preclinical phase of AD

  1999cites this paper
• Transgenic animals relevant to Alzheimer's disease.

  1999cites this paper
• Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease.

  1999cites this paper
• Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease.

  1999cites this paper
• Assessing the machinery of mind: synapses in neuropsychiatric disorders.

  1999cites this paper
• Neuropathological Correlates of Dementia in Alzheimer’s Disease

  1999cites this paper
• Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

  1998cites this paper
• Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?

  1998cites this paper
• Localization of a novel septin protein, hCDCrel‐1, in neurons of human brain

  1998cites this paper
• Characterization of perforant path lesions in rodent models of memory and attention

  1998cites this paper
• Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.

  1998cites this paper
• Neocortical Synapse Density and Braak Stage in the Lewy Body Variant of Alzheimer Disease: A Comparison with Classic Alzheimer Disease and Normal Aging

  1998cites this paper
• SNAP-25 deficit and hippocampal connectivity in schizophrenia.

  1998influential citation
• Abnormalities of neural circuitry in Alzheimer's disease

  1998cites this paper
• Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions

  1997cites this paper
• Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.

  1997cites this paper
• Neuroimmunomodulation via limbic structures--the neuroanatomy of psychoimmunology.

  1997cites this paper
• Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer’s disease and Lewy body variant

  1997cites this paper
• Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway.

  1997cites this paper
• Dementia with Lewy Bodies Versus Pure Alzheimer Disease: Differences in Cognition, Neuropathology, Cholinergic Dysfunction, and Synapse Density

  1997cites this paper
• Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.

  1997cites this paper